Home
>
National Drug Code (NDC)
>
Levitra
Levitra - 0173-0831-13 - (vardenafil hydrochloride)
Drug Information of Levitra
| Product NDC: | 0173-0831 |
| Proprietary Name: | Levitra |
| Non Proprietary Name: | vardenafil hydrochloride |
| Active Ingredient(s): | 20 mg/1 & nbsp; vardenafil hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Levitra
| Product NDC: | 0173-0831 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021400 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030825 |
Package Information of Levitra
| Package NDC: | 0173-0831-13 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0173-0831-13) |
NDC Information of Levitra
| NDC Code | 0173-0831-13 |
| Proprietary Name | Levitra |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0173-0831-13) |
| Product NDC | 0173-0831 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | vardenafil hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20030825 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | VARDENAFIL HYDROCHLORIDE TRIHYDRATE |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
